Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Article in JCO Precision Oncology (February 2024)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
Chemotherapeutic Activity of Imidazolium-Supported Pd(II) o-Vanillylidene Diaminocyclohexane Complexes Immobilized in Nanolipid as Inhibitors for HER2/neu and FGFR2/FGF2 Axis Overexpression in Breast Cancer Cells
Article in Pharmaceuticals (December 2023)
Tailoring Potential Natural Compounds for the Treatment of Luminal Breast Cancer
Article in Pharmaceuticals (October 2023)